From: Evaluation of the effectiveness of greater occipital nerve blockade in menstrual migraine
PMM (n = 15) | MRM (n = 18) | MM(n = 33) | P | |
---|---|---|---|---|
Age (years) | 41,3 ± 6,4 | 38,9 ± 5,7 | 40 ± 6.1 | 0,271 |
BMİ Normal Overweight/obese | 4(%26.7) 11(%73.3) | 6(%33.3) 12(%66.7) | 10(%30.3) 23(%69.7) | 0,702 |
Educational Status Primary school and below Middle school and above | 10(%66.7) 5(%33.3) | 6(%33.4) 12(%66.6) | 16(%48.4) 17(%51.6) | 0,070 |
Age of onset MM (mean ± SD) | 31,3 ± 7,2 | 24,4 ± 9,0 | 27.58 ± 8,8 | 0,024 |
Headache Frequency (days/month) (mean ± SD) | 6,0 ± 4,5 | 12,2 ± 6,9 | 9.3 ± 6.6 | 0,004 |
Medication Overuse (MO) | 5(%33.3) | 14(%77.8) | 19(%57.5) | 0,027 |
Response to Treatment | 12 (%88.0) | 12(%66.7) | 24(%72.7) | 0,458 |